UK Parliament / Open data

Advanced Therapy Medicinal Products

Written question asked by Nicholas Dakin (Labour) on Monday, 9 September 2019, in the House of Commons. It was due for an answer on Tuesday, 3 September 2019. It was answered by Jo Churchill (Conservative) on Monday, 9 September 2019 on behalf of the Department of Health and Social Care.

Question

To ask the Secretary of State for Health and Social Care, what assessment has been made of the suitability of NICE’s process of medicines appraisal for new cell and gene therapy therapies.

Answer

It has not proved possible to respond to the hon. Member in the time available before Prorogation.

Type
Written question
Reference
282322
Session
2017-19
Related items
Speaker’s Statement
Wednesday, 25 September 2019
Parliamentary proceedings
House of Commons
Notes
Supreme Court ruling of 24 September that Parliament was not prorogued on 9 September.
Subjects
National Institute for Health and Care Excellence
Research
Advanced therapy medicinal products
Link
View this Written question on www.parliament.uk
Back to top